Research Article
Worse Disease Prognosis Is Associated to an Increase of Platelet-Derived Extracellular Vesicles in Hospitalized SARS-CoV-2 Patients
Table 1
Demographic and clinical features of hospitalized SARS-CoV-2+ patients.
| | Median (Q1-Q3) |
| | Age (years) | 67 (58-80) | | Gender (M/F), (%) | 55/23 (71%) | | WBC1 (×103/μL) | 8.61 (6.36-11.26) | | Lymphocytes (×103/μL) | 0.81 (0.59-1.13) | | Creatinine (mg/dL) | 0.86 (0.74-1.16) | | AST2 (mU/mL) | 39 (30-49) | | ALT3 (mU/mL) | 34.5 (20-47.5) | | CRP4 (mg/dL) | 6.44 (2.48-13.95) | | PCT5 (ng/mL) | 0.13 (0.05-0.28) | | PLTs (×103/μL) | 216 (173-300) | | PT-INR6 | 1.02 (0.96-1.08) | | Ferritin (ng/mL) | 564 (171-1106) | | LDH7 (U/L) | 587.5 (495-752) | | D-dimer (μg/L) | 1070 (609-1471) | | IL8-6 | 14.75 (6.4-27) | | SpO2/FiO2 | 427.5 (400-447) | | PaO2/FiO2 | 247 (214-295) | | SpO2 | 89 (85-94) | | FiO2 | 21 (21-21) | | Respiratory rate | 25 (15-30) |
|
|
1White blood cell, 2aspartate aminotransferase, 3alanine aminotransferase, 4C-reactive protein, 5procalcitonin, 6prothrombin time-international normalized ratio, 7lactate dehydrogenase, and 8interleukin.
|
